Adult polyglucosan body disease masquerading as "ALS with dementia of the Alzheimer type": An exceptional phenotype in a rare pathology

Alzheimer Disease and Associated Disorders

Volumn 26, Issue 1, 2012, Pages 96-99

  Segers, Kurt ^a,b   Kadhim, Hazim ^b,c   Colson, Catherine ^a,b   Duttmann, Ruth ^d   Glibert, Gérald ^d  

^a Memory Clinic   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d Brugmann University Hospital (ULB)   (Belgium)

Author keywords

adult polyglucosan body disease; Alzheimer disease; amyotrophic lateral sclerosis; cognitive deficits; dementia

Indexed keywords

CHOLESTEROL; CREATINE KINASE; LISINOPRIL; MYOGLOBIN; RILUZOLE; RIVASTIGMINE; SIMVASTATIN;

ADULT POLYGLUCOSAN BODY DISEASE; AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR HORN CELL; APATHY; APRAXIA; ARTICLE; AUTOPSY; BABINSKI REFLEX; BRAIN CORTEX ATROPHY; BRAIN HEMORRHAGE; BRAIN SPONGIOSIS; BRONCHOPNEUMONIA; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COGNITIVE DEFECT; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE DURATION; DISORIENTATION; ELECTROPHYSIOLOGY; FASCICULATION; FLUENCY DISORDER; GLOSSOPHARYNGEAL NERVE; HEARING LOSS; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERREFLEXIA; LOADING DRUG DOSE; LUNG EDEMA; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; MORTALITY; MUSCLE ATROPHY; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NEUROPIL; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROSTATECTOMY; PROTEIN BLOOD LEVEL; RARE DISEASE; WEIGHT REDUCTION; WHITE MATTER;

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; COGNITION DISORDERS; GLUCANS; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE;

EID: 84857788837     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31821cc65d     Document Type: Article

References (10)

1. Robitaille Y, Carpenter S, Karpati G, et al. A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal ageing. Brain. 1980;103:315-336. (Pubitemid 10046626)
2. Gray F, Gherardi R, Marshall A, et al. Adult polyglycosan body disease (APGBD). J Neuropath Exp Neurol. 1988;47: 459-474.
3. Savage G, Ray F, Halmagyi M, et al. Stable neuropsychological deficits in adult polyglucosan body disease. J Clin Neurosci. 2007;14:473-477. (Pubitemid 46453183)
4. Milde P, Guccion JG, Kelly J, et al. Adult polyglucosan body disease. Arch Pathol Lab Med. 2001;125:519-522.
5. McDonald TD, Faust PL, Bruno C, et al. Polyglucosan body disease simulating amyotrophic lateral sclerosis. Neurology. 1993;43:785-790. (Pubitemid 23121975)
6. Bak TH. Overlap Syndromes. In: Hodges JR. ed. Frontotemporal dementia syndromes. 1st ed. Cambridge: Cambridge University Press; 2007:80-101.
7. Mackenzie IR. The neuropathology of FTD associated With ALS. Alzheimer Dis Assoc Disord. 2007;21:S44-S49.
8. Le Ber I, Camuzat A, Berger E, et al. Chromosome 9-p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology. 2009;72:1669-1676.
9. McKhann G, Dracham D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944. (Pubitemid 14076461)
10. Edwards IR, Star K, Kiuru A. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase. Drug Saf. 2007;30:515-525. (Pubitemid 46873076)